Breast Reconstruction With Silicone Implants

2

Review clinical trials related to Breast Reconstruction With Silicone Implants. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Post-market Prospective Clinical Study of Eurosilicone Luna Mammary Implants

The goal of this observational, non-comparative study is to determine the frequency and rate of rupture and capsular contracture Baker III-IV of Eurosilicone Luna range of breast implants, over a 10-year period following surgical implantation in female population between 18 and 65 years old undergoing primary or revision of breast augmentation or breast reconstruction.

Participants needed: 650
Trial details
Age: 18-65Biological sex: FemaleType: ObservationalSponsor: GCA (Eurosilicone)Updated: Jul 1, 2026Locations: 2
Eligibility criteria

The target population includes subjects undergoing augmentation or reconstructiv... [+1]

Subjects with a BMI >35. [+11]

Status: Recruiting

Post-market Prospective Clinical Study of Nagor Perle Mammary Implants

Patients can undergo breast implant surgery for multiple reasons; cosmetic and reconstructive being the primary indications. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants. This study is designed to collect data on a new generation of smooth mammary implants to assess the long term performance and safety data on this type of gel-filled mammary breast implant. The two main complications of breast implants are capsular contracture and rupture; these complications can take years to develop. The study is designed to evaluate the occurrence of these two primary complication as well as other secondary complications over a period of 10 years. Patient follow up will be carried out pre-operatively and post operatively at 12 months and then 3, 5, 8 and 10 years thereafter. The study will be carried out over 10 years to adequately assess complications which may only occur over the lifetime of the device such as systemic complications

Participants needed: 60
Trial details
Age: 18-65Biological sex: FemaleType: ObservationalSponsor: GCA (Eurosilicone)Updated: Jun 29, 2026Locations: 1
Eligibility criteria

Genetic female subjects aged ≥18 and ≤65 [+1]

Subjects undergoing implant augmentation with a BMI > 30 and undergoing reconstr... [+12]